Plataforma de Turismo Médico #1 desde 2014

Los mejores oncólogos del tratamiento de Leiomiosarcoma — TOP-26 médicos

author
El contenido cumple con la Política editorial de Bookimed y está revisado médicamente por
Fahad Mawlood - Médico general. Ganador de 4 premios científicos. Sirvió en Asia Occidental. Es el ex jefe del equipo médico que soporta a pacientes de habla árabe. Ahora es responsable del procesamiento de datos y la precisión del contenido médico.
image
Yesim Yildirim
Oncólogo clínico
20 años de experiencia
4.6
472 reseñas
Turquía, Estambul
Centro médico Anadolu

Yesim Yildirim

Oncólogo clínico
20 años de experiencia

acreditaciones:

European Society of Medical Oncology
European School of Oncology
  • Especializado en el tratamiento del leiomiosarcoma mediante cirugía, radioterapia, quimioterapia, terapia dirigida e inmunoterapia.
  • Cuenta con experiencia formativa internacional en instituciones médicas de Israel, Reino Unido y Turquía.
  • Certificado por la Sociedad Europea de Oncología Médica (ESMO).
  • Miembro de ESMO y ESO, adhiriéndose a los más altos estándares oncológicos.
  • Habla inglés, ruso (nivel B1) y turco.
Mostrar más
4.6
472 reseñas
Cita con el médico precio a consultar
Radioterapia para sarcomas $10000 - $15000
CyberKnife $8500 - $14000
Radioterapia para el cáncer colorrectal
Más tratamientos
image
Mustafa Solak
Oncólogo clínico
18 años de experiencia
4.5
137 reseñas
Turquía, Estambul
Hospital Hisar Intercontinental

Mustafa Solak

Oncólogo clínico
18 años de experiencia
  • Especializado en el tratamiento del leiomiosarcoma mediante cirugía, radioterapia, quimioterapia y terapia dirigida.
  • El médico tiene experiencia de práctica internacional en el Centro Oncológico MD Anderson de la Universidad de Texas, EE.UU.
  • Licenciado por la Facultad de Medicina de la Universidad Hacettepe, realizó la residencia en el Hospital Universitario y de Investigación Sisli Etfal de Estambul.
  • Realizó una beca en el Instituto Oncológico de la Universidad Hacettepe, centrada en tratamientos avanzados del cáncer.
  • Es miembro de la Sociedad Turca de Oncología Médica y de la Sociedad Americana de Oncología Clínica.
Mostrar más
image
Esra Ozbasli
Obstetra-ginecóloga
21 años de experiencia
Turquía, Estambul
Assoc. Prof. Dr. Esra Özbaşlı OBGYN & Genital Aesthetics

Esra Ozbasli

Obstetra-ginecóloga
21 años de experiencia

I am Assoc. Prof. Dr. Esra Ozbasli, a board-certified OB-GYN and Genital Cosmetic Surgeon with over 21 years of experience. My dedication to excellence and patient satisfaction has established our clinic as a trusted destination for women’s health and aesthetic procedures in Nişantaşı, heart of Istanbul.I received my medical degree from Istanbul University Cerrahpaşa Medical Faculty, followed by specialized training in obstetrics and gynecology at Istanbul Zeynep Kamil Women and Children Diseases Training and Research Hospital. After working as an academician at Acıbadem University for 12 years, I became an associate professor there by exhibiting my scientific articles in many respected international scientific journals published in Pubmed. During this period, I trained many medical students and OBGYN specialist colleagues in the field of genital aesthetics surgery, urogyneacology. My advanced training in genital cosmetic surgery provided me with expertise in the latest techniques for enhancing and restoring female genital aesthetics and function. I hold certifications in Genital Aesthetics and Cosmetic Gynecology (Vaginal Rejuvenation), Certificate of da Vinci System Training as a Console Surgeon (since 2013) and the ECFMG certificate for foreign medical graduates. Additionally, I possess advanced-level English proficiency (TOEFL score 600 in 2003), ensuring clear communication with international patients. I have completed an observership in New York University in 2005. 

 

Specialized Services:

 • Genital Cosmetic Surgery: Labioplasty, hudoplasty, vaginoplasty, lipofilling, PRP therapy, hyaluronic acid filling, hymenoplasty, labia majora plasty, vulvar whitening, G-shot, O-shot, treatment of atrophic vagina, lichen sclerosis, and vaginal laxity.

 • Minimally Invasive Surgery: Laparoscopy, robotic surgery, hysteroscopy for fibroids, endometrioma, endometrial polyps, ovarian cysts, tubal ligation, intrauterine septum resection, abnormal vaginal bleeding, and hysterectomy.

 • Menopause Treatment: Bioidentical hormone therapy for managing menopausal symptoms, mezotherapy and laser for atrophic vagina.

•Urinary incontinence treatment: Sling operations (TOT), hyaluronic acid filling, laser treatments.

• Cervical Dysplasia Diagnosis and Treatment: Co-test, PAP-smear, colposcopy guided biopsy and LEEP conization.

 

International Patient Services: 

We offer a package service for our foreign patients that includes: 

• Arrangements for flights and hotel stays • Pick-up service from the airport and hotel • Assistance throughout your stay to ensure a smooth and stress-free experience • Sightseeing of Istanbul before the surgery if requested

 

Why Choose Us: 

• Expertise: With over two decades of specialized experience, I offer advanced surgical techniques and personalized care. 

• Innovation: Utilizing the latest technology in minimally invasive and cosmetic procedures to ensure optimal results.

 • Quality Care: I perform my surgeries in A-class hospitals equipped with advanced technological surgical devices. 

• Compassion: Committed to providing a comfortable, supportive, and private environment for all patients. 

Mostrar más
Labioplastia

Contenido sensible

Más información

Fotos de antes y después de
Labioplastia
image
Ilker Nihat Okten
Oncólogo clínico
18 años de experiencia
3.5
3 reseñas
Turquía, Estambul
Istanbul Oncology Hospital

Ilker Nihat Okten

Oncólogo clínico
18 años de experiencia
El Dr. Ilker Nihat Okten es oncólogo médico certificado por la Sociedad Europea de Oncología Médica (ESMO). Ha participado como subinvestigador en múltiples ensayos clínicos de fase III para diversos tipos de cáncer y tiene varias publicaciones en el campo de la oncología.Mostrar más
Cómo elegir el médico y la clínica adecuados: Consejos de expertos
Al elegir un médico o una clínica, tenga en cuenta estos puntos clave:
Revise las credenciales
Verifique las certificaciones de entidades como ISAPS, JCI, etc.
Revise las tasas de éxito
Elija médicos con una amplia experiencia en su tratamiento específico.
Lea las reseñas de los pacientes
Reseñas de pacientes reales de Bookimed para conocer su experiencia.
Garantía de comunicación
Elija clínicas que ofrezcan servicio de traducción para facilitar el tratamiento.
Pregunte sobre los servicios
Confirme si proporcionan alojamiento y traslados, y compruebe los costes.
Elegir una clínica en el extranjero puede ser estresante. En Bookimed, con más de 800K pacientes ayudados, entendemos sus preocupaciones. Sabemos cómo encontrar médicos de confianza, las mejores opciones calidad-precio y soluciones incluso para casos complejos. Estamos aquí para guiarle en cada paso de su viaje médico.
image
Yan Matsiivskiy
Jefe del Equipo de coordinadores médicos
image
Murat Sari
Oncólogo clínico
8 años de experiencia
5.0
1 reseñas
Turquía, Estambul
Hospital Distrital Medipol Acibadem

Murat Sari

Oncólogo clínico
8 años de experiencia

Education and Career


2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

Medicine Department of Internal Medicine

2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

Memberships in Scientific Organizations

ASCO

ESMO

TTOD 

AVOD 

Publications

In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

Awards Received

EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

Speeches Delivered at National Congresses, Conferences, and Symposia:

 

Courses, Meetings, and Certificates

ESMO certified Medical Oncologist since 2019

Mostrar más
image
Nese Guney
Oncólogo clínico
26 años de experiencia
Turquía, Estambul
Biruni University Hospital

Nese Guney

Oncólogo clínico
26 años de experiencia
La Dra. Nese Guney es una oncóloga médica con 26 años de experiencia laboral, 9 de ellos específicamente en oncología. Es experta en diversos procedimientos como mastectomía, resección tiroidea, extirpación de cáncer de colon, braquiterapia, terapia con haz de protones, cirugía de melanoma y otros. Sus investigaciones incluyen publicaciones sobre temas relacionados con el linfoma y la metástasis ovárica.Mostrar más
image
Abdullah Sakin
Oncólogo/mamólogo
17 años de experiencia
5.0
2 reseñas
Turquía, Estambul
Medipol Bahçelievler Hospital

Abdullah Sakin

Oncólogo/mamólogo
17 años de experiencia

 

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

 

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

 

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

 

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

 

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

 

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

 

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

 

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

 

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

 

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

 

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

 

2008 - 2012 Haseki Training and Research Hospital

 

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

 

 

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

 

Mostrar más
5.0
2 reseñas
Cita con el médico precio a consultar
Radioterapia para sarcomas $4000 - $6000
Radioterapia para el cáncer colorrectal $4000 - $6000
Más tratamientos
image
Evrim Metcalfe
Radio oncólogo
26 años de experiencia
5.0
2 reseñas
Turquía, Estambul
Medipol Bahçelievler Hospital

Evrim Metcalfe

Radio oncólogo
26 años de experiencia

Experience

2021 - 2022

Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

2021 - 2022

Department of Radiation Oncology, Biruni University Faculty of Medicine

2020 - 2021

Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

2017 - 2020

Clinical Manager of Radiation Oncology, Neolife Medical Center

2016 - 2017

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2011 - 2016

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2010 - 2011

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2008 - 2010

Radiation Oncology Clinic, Samsun Training and Research Hospital (Education Coordinator)

2006

Medical Faculty, Dokuz Eylül University

2006 - 2008

Radiation Oncology Clinic, Samsun Mehmet Aydın State Hospital (Compulsory Service)

2000 - 2006

Medical Faculty, Dokuz Eylül University

 

Education

2022

Biruni University Faculty of Medicine, Department of Radiation Oncology, Faculty Member, Professor Doctor

2022

Anadolu University Open Education Faculty Undergraduate Program, Cultural Heritage and Tourism

2021

Feyziye Schools Foundation Işık University Health Services Vocational School, Faculty Member, Associate Professor Doctor

2017

Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Faculty Member

2017

Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Associate Professor Doctor

2006

Samsun Training and Research Hospital, Specialist Doctor, Compulsory Service

2006

Dokuz Eylül University Faculty of Medicine, Department of Radiation Oncology, Medical Specialization

1998

Ege University, Faculty of Medicine

 

 

Mostrar más
5.0
2 reseñas
Cita con el médico precio a consultar
Radioterapia para sarcomas $4000 - $6000
Radioterapia para el cáncer colorrectal $4000 - $6000
Más tratamientos
image
Tahsin Ozadli
Oncólogo clínico
21 años de experiencia
4.7
33 reseñas
Turquía, Estambul
Valued Med Hub Hospitals

Tahsin Ozadli

Oncólogo clínico
21 años de experiencia

Education and Expertise

Selcuk University Meram Faculty of Medicine - Medical Education

Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization

 

Experience

Malatya State Hospital Internal Diseases Clinic

Ankara Oncology Hospital Medical Oncology Clinic

Erzurum Regional Training and Research Hospital Medical Oncology Clinic


AREAS OF INTEREST

Lung cancer

esophageal cancer

Gastric cancer

breast cancer

Gastrointestinal surgery

https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr 

Mostrar más
image
Sezer Saglam
Oncólogo clínico
27 años de experiencia
5.0
27 reseñas
Turquía, Estambul
Florence Nightingale Hospital

Sezer Saglam

Oncólogo clínico
27 años de experiencia

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

 

Education:

He became Professor (22/April /2016)

Medical Oncology

 

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

 

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

 

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

 

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

 

Ege University Medical Faculty (1985-1991)

 

Professional Experience

 

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

 

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

 

Membership

 

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Mostrar más
image
Osman Kostek
Oncólogo clínico
20 años de experiencia
5.0
1 reseñas
Turquía, Estambul
Hospital Distrital Medipol Acibadem

Osman Kostek

Oncólogo clínico
20 años de experiencia

Education

  • (2004 – 2011), Faculty of Medicine/ Inonu University/ Malatya, Turkiye
  • (2011 – 2015), Department of Radiology/ Bagcilar Training and Research Hospital/ Istanbul, Turkiye

Career

  • (2016 – 2020), Diagnostic and Interventional Radiologist/ Mus State Hospital/ Mus,Turkiye
  • (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology/ Sakarya University Training and Research Hospital/ Sakarya, Turkiye
  • (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology /Sakarya University Training and Research Hospital/ Sakarya, Turkiye
  • (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology /Medipol University Hospital/ Istanbul, Turkiye
Mostrar más
image
Hamza Ugur Bozbey
Oncólogo clínico
10 años de experiencia

Hamza Ugur Bozbey

Oncólogo clínico
10 años de experiencia
Turquía, Estambul
Clínica Uniqacare
image
Muhammed Gomec
Cirujano colorectal
15 años de experiencia
5.0
1 reseñas

Muhammed Gomec

Cirujano colorectal
15 años de experiencia
Turquía, Sivas
Medicana Sivas Hospital
image
Alandag Celal
Oncólogo clínico
15 años de experiencia
5.0
1 reseñas

Alandag Celal

Oncólogo clínico
15 años de experiencia
Turquía, Sivas
Medicana Sivas Hospital
image
Nail Paksoy
Oncólogo/mamólogo
13 años de experiencia
5.0
2 reseñas
Turquía, Estambul
Medipol Bahçelievler Hospital

Nail Paksoy

Oncólogo/mamólogo
13 años de experiencia

acreditaciones:

ESMO Board Certification in Medical Oncology


PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

 

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

 

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

  • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
  • Role: Subinvestigator

2. PFİZER

  • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
  • Role: Subinvestigator

3. RECITE - AMGEN

  • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
  • Role: Subinvestigator

4. NAVIGATE - BAYER

  • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
  • Role: Subinvestigator

5. RUBY - Tesaro (PRA)

  • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
  • Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

  • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
  • Role: Subinvestigator

7. ASTRA ZENECA

  • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
  • Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

  • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
  • Role: Subinvestigator
  •  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
  • Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
  • Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

  • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
  • Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

  • Authors: Paksoy, Nail, et al.
  • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

  • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
  • Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

  • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
  • Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

  • Authors: HAS SIMSEK, Duygu, et al.
  • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

  • Authors: FERHATOGLU, Ferhat, et al.
  • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

  • Authors: GÜRBÜZ, Mustafa, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

  • Authors: AY, Seval, et al.
  • Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

  • Authors: CIL, Ibrahim, et al.
  • Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

  • Authors: HIZAL, Mutlu, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
  • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
  • Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

  • Authors: DEMIR, Semra, et al.
  • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

  • Authors: ÖZDEMIR, Seçil Kepil, et al.
  • Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

  • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
  • Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

  • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
  • Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
  • Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
  • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

  • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
  • Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

  • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
  • Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

  • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
  • Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

  • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
  • Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

  • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
  • Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

 

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

  • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

  • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

  • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

  • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

  • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

  • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

  • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

  • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

 

 

Mostrar más
5.0
2 reseñas
Cita con el médico precio a consultar
Radioterapia para sarcomas $4000 - $6000
Radioterapia para el cáncer colorrectal $4000 - $6000
Más tratamientos
image
Seyda Gunduz
Oncólogo clínico
14 años de experiencia
4.3
16 reseñas

Seyda Gunduz

Oncólogo clínico
14 años de experiencia
Turquía, Estambul
Istinye University Liv Hospital Bahcesehir
image
Ugur Ekici
Cirujano colorectal
24 años de experiencia
2.0
1 reseñas
Turquía, Estambul
Medicana Bahcelievler Hospital

Ugur Ekici

Cirujano colorectal
24 años de experiencia
Asoc. El Dr. Ugur Ekici es un cirujano general altamente experimentado con más de 20 años de experiencia y una especialidad en obesidad y cirugía metabólica, cirugía laparoscópica avanzada, cirugía de tiroides y paratiroides y cirugía de cáncer. Se graduó de la Facultad de Medicina de la Universidad de Erciyes en 2000 y completó su formación especializada en la Clínica de Cirugía General del Hospital Şişli Etfal en 2009. Ha publicado numerosos artículos en revistas internacionales arbitradas.Mostrar más
image
Ersin Ozturk
Cirujano colorectal
26 años de experiencia
5.0
1 reseñas
Turquía, Bursa
Medicana Bursa Hospital

Ersin Ozturk

Cirujano colorectal
26 años de experiencia
Ersin Öztürk, MD Profesor de Medicina es experto en Cirugía General, Oncología Quirúrgica, Fisiología, Cirugía Gastrointestinal, Cirugía Laparoscópica, Cirugía de Obesidad, Cirugía de Hernia y Proctología. Tiene una amplia experiencia en su campo, habiendo completado residencias, becas de investigación y puestos docentes en varias instituciones. Actualmente, es Profesor de Medicina en el Hospital Medicana Bursa, Departamento de Cirugía General.Mostrar más
image
Kayihan Engin
Radio oncólogo
39 años de experiencia
5.0
1 reseñas
Turquía, Bursa
Medicana Bursa Hospital

Kayihan Engin

Radio oncólogo
39 años de experiencia

El Dr. tiene un diploma médico de la Facultad de Medicina de la Universidad de Uludağ, Bursa, Turquía (1983), una beca posdoctoral en Termorradioterapia de la Universidad Thomas Jefferson, Filadelfia, PA (1990-1994) y una residencia en Oncología Radioterápica del Centro de Oncología y Nuclear. Medicina, Estambul, Turquía (1990). También ocupó cargos como profesor, presidente y coordinador de acreditación de la facultad en la Facultad de Medicina de la Universidad de Uludağ (1991-2005), profesor y director en el Centro Médico Anadolu (2004-2017) y director en el Hospital Internacional Ceylan y el Hospital Medicana Bursa (2017). -regalo).

Mostrar más
image
Hakan Seçkin
Neurocirujano
36 años de experiencia
5.0
1 reseñas

Hakan Seçkin

Neurocirujano
36 años de experiencia
Turquía, Bursa
Medicana Bursa Hospital

Política editorial de Bookimed

Bookimed, una plataforma líder mundial en turismo médico, se compromete a ayudar a los clientes que buscan un tratamiento para el leiomiosarkoma ofreciéndoles asistencia experta y soluciones médicas confiables para cada situación. Se utiliza un sistema de clasificación automático inteligente para elaborar listas de clínicas transparentes, mantenidas meticulosamente por un científico de datos que utiliza IA para mayor precisión. La plataforma garantiza la autenticidad al publicar reseñas de pacientes reales después de sus tratamientos. Bookimed ofrece soluciones médicas integrales, con actualizaciones de las clínicas para garantizar la confiabilidad. El contenido sobre el tratamiento del leiomiosarkoma, elaborado por autores médicos experimentados y revisado por especialistas, cumple con las pautas editoriales de Bookimed , lo que refleja el compromiso de la plataforma de brindar información de salud clara y de alta calidad. Para obtener más detalles o consultas, no dude en contactarnos en marketing@bookimed.com o obtenga más información sobre nosotros y nuestra misión aquí .

Experto de Leiomiosarcoma en el Consejo de Asesoría Médica de Bookimed

image

El Dr. Yesim Yıldırım es profesor de Oncología Médica en el Centro Médico Anadolu y miembro de la Sociedad Europea de Oncología Médica (ESMO). Se especializa en inmunoterapia del cáncer y terapias dirigidas, diagnóstico y tratamiento de neoplasias malignas y ha publicado más de 80 publicaciones, resúmenes y libros internacionales y nacionales. También tiene un MBA en Gestión de la Salud y domina los idiomas inglés, ruso y turco.